Detalhe da pesquisa
1.
Treatment of Non-Small Cell Lung Cancer with Atypical EGFR Mutations.
Curr Treat Options Oncol
; 24(12): 1802-1814, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38095779
2.
Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
J Natl Compr Canc Netw
; 19(8): 915-921, 2021 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33878726
3.
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(12): 1441-1464, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902832
4.
Impact of Extended-Interval Versus Standard Dosing of Zoledronic Acid on Skeletal Events in Non-Small-Cell Lung Cancer and Small-Cell Lung Cancer Patients With Bone Metastases.
Ann Pharmacother
; 55(6): 697-704, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33070623
5.
Emerging drugs for small cell lung cancer: a focused review on immune checkpoint inhibitors.
Expert Opin Emerg Drugs
; 25(3): 353-366, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32683991
6.
A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 25(2): 128-134, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37977950
7.
Selective Personalized RadioImmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial (SPRINT).
J Clin Oncol
; 42(5): 562-570, 2024 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37988638
8.
Subcutaneous versus Intravenous Amivantamab, both in Combination with Lazertinib, in Refractory EGFR-mutated NSCLC: Primary Results from the Phase 3 PALOMA-3 Study.
J Clin Oncol
; : JCO2401001, 2024 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38857463
9.
Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy.
Cancer Cell
; 41(2): 304-322.e7, 2023 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36638784
10.
Association of Aurora-A (STK15) kinase polymorphisms with clinical outcome of esophageal cancer treated with preoperative chemoradiation.
Cancer
; 118(17): 4346-53, 2012 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22213102
11.
An evaluation of sotorasib for the treatment of patients with non-small cell lung cancer with KRASG12C mutations.
Expert Opin Pharmacother
; 23(14): 1569-1575, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36217844
12.
Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer.
Lung Cancer
; 163: 35-41, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34896803
13.
Cellular engagement and interaction in the tumor microenvironment predict non-response to PD-1/PD-L1 inhibitors in metastatic non-small cell lung cancer.
Sci Rep
; 12(1): 9054, 2022 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641540
14.
Immune Checkpoint Inhibitors and Risk of Type 1 Diabetes.
Diabetes Care
; 45(5): 1170-1176, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35238899
15.
Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline.
J Clin Oncol
; 40(12): 1356-1384, 2022 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34936470
16.
Case report: A persistently expanded T cell response in an exceptional responder to radiation and atezolizumab for metastatic non-small cell lung cancer.
Front Immunol
; 13: 961105, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36159875
17.
Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study.
JMIR Cancer
; 8(2): e33859, 2022 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35588361
18.
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination.
Nat Med
; 27(1): 152-164, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33398162
19.
Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity.
Cancer Cell
; 39(7): 973-988.e9, 2021 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115989
20.
A Mutation in the SH2 domain of STAT2 prolongs tyrosine phosphorylation of STAT1 and promotes type I IFN-induced apoptosis.
Mol Biol Cell
; 18(7): 2455-62, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17442890